Patent Assignment
Reel/Frame 059905/0534
Assignment of Assignor's Interest
Recorded: 2022-05-13
Pages: 7
Assignee
CHEMOCENTRYX, INC.
850 MAUDE AVENUE, MOUNTAIN VIEW, CALIFORNIA, 94043
Covered Properties
(3)
Compositions and Methods for Treating CCR9-Mediated Diseases Using CCR9 Inhibitor and Anti-Tnf-Alpha Blocking Antibodies
PCT:
PCT/US2020/061569 ↗
Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-Tnf-Alpha Blocking Antibodies
Patent:
10,792,360 →
Application:
16/740,861 →
Compositions and Methods for Treating CCR9-Mediated Diseases using CCR9 Inhibitor and Anti-TNF-Alpha Blocking Antibodies
Application:
17/064,550 →
Publication:
US 2021/0154292
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.